$18.90
2.05[12.17%]
At close: May 8
$18.90
0[0.00%]
After Hours: 4:20PM EDT
Denali Therapeutics
(NASDAQ:DNLI)Denali Therapeutics Stock (NASDAQ:DNLI), Earnings Estimates, EPS, and Revenue
Denali Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS
$-0.680
Quarterly Revenue
$0K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$330.5M
Analyze the earnings history of Denali Therapeutics using advanced sorting and filters.
No data available to display
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
|---|
FAQ
When is Denali Therapeutics (NASDAQ:DNLI) reporting earnings?
Denali Therapeutics (DNLI) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
What were the latest earnings per share (EPS) for Denali Therapeutics (NASDAQ:DNLI)?
The Actual EPS was $-0.68, which beat the estimate of $-0.70.
What were Denali Therapeutics’s (NASDAQ:DNLI) revenues?
The Actual Revenue was $0K, which missed the estimate of $14M.
Browse earnings estimates, EPS, and revenue on all stocks.